| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6183774 | Gynecologic Oncology | 2013 | 4 Pages |
Abstract
⺠Early-stage papillary serous and clear cell endometrial cancer patients received HDR vaginal brachytherapy. ⺠A low-dose brachytherapy regimen of 24 Gy in 6 fractions resulted in a low rate of vaginal relapse. ⺠This low-dose regimen was safe and without toxicity.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Kanokpis Townamchai, Ross Berkowitz, Mandar Bhagwat, Antonio L. Damato, Scott Friesen, Larissa J. Lee, Ursula Matulonis, Desmond O'Farrell, Akila N. Viswanathan,